Elite Health Systems Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $0 | $0 | $0 | $1.1M | $3.2M | $3.1M | $3.4M |
| Cost of Revenue | $906.0K | $0 | — | — | — | — | — | — |
| Gross Profit | $118.0K | $0 | — | — | — | — | — | — |
| Gross Margin | 11.5% | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.0M | $1.8M | $765.0K | $1.4M | $1.1M | $1.2M | $1.2M | $1.3M |
| Operating Income | $-3.8M | $-1.8M | $-765.0K | $-1.4M | $-88.0K | $1.6M | $1.5M | $131.0K |
| Operating Margin | -374.9% | — | — | — | -8.3% | 50.9% | 48.5% | 3.8% |
| Interest Expense | — | — | $2.0K | $0 | $3.0K | $25.0K | $91.0K | $113.0K |
| Pretax Income | $-7.8M | $-2.2M | $-816.0K | $-1.5M | $-553.0K | $856.0K | $151.0K | $-613.0K |
| Income Tax Expense | $0 | $-163.0K | $0 | $39.0K | $420.0K | $323.0K | $9.0K | $-192.0K |
| Net Income | $-7.8M | $-2.1M | $-816.0K | $-1.3M | $-881.0K | $533.0K | $142.0K | $-421.0K |
| Net Margin | -762.1% | — | — | — | -83.0% | 16.8% | 4.6% | -12.3% |
| EPS (Basic) | $-0.35 | $-0.13 | $-0.09 | $-0.09 | $-0.11 | $0.07 | $0.02 | $-0.05 |
| EPS (Diluted) | — | — | $-0.17 | $-0.17 | $-0.11 | $0.07 | $0.02 | $-0.05 |
| Shares Outstanding (Basic) | 22.6M | 15.4M | 9.3M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M |
| Shares Outstanding (Diluted) | 22.6M | 15.4M | 9.3M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |